glycosylated hemoglobin A1c

glycosylated hemoglobin A_1c

Glycated hemoglobin A_1c, glycohemoglobin A_1c, hemoglobin A_1c The most abundant and measured GHA₁ Ref range > 10% poor glucose control; < 7-8% good glucose control. See Advanced glycosylation endproducts, Fast hemoglobin, Glycosylated hemoglobin A₁.

References in periodicals archive ?

Hometelecare service model intervention has no significant effect on Glycosylated hemoglobin A1c (A1c)

The effectiveness of the telehomecare for self-care behaviors of patients with diabetes in Taiwan: A consecutive observational study

NWC: normal weight control; OC: obese control; NS: not significant; DM: diabetes mellitus; BMI: body mass index; WHR: waist-to-hip ratio; SBP: systolic blood pressure; DBP: diastolic blood pressure; FPG: fasting plasma glucose; FINS: fasting insulin; HOMA-IR: homeostasis model assessment of insulin resistance; HbA1c: glycosylated hemoglobin A1C; TC: total cholesterol; LDL-C: low-density lipoprotein-cholesterol; HDL-C: high- density lipoprotein cholesterol; TG: triglycerides; hs-CRP: high- sensitivity C-reactive protein.

Serum Vaspin Concentration in Elderly Type 2 Diabetes Mellitus Patients with Differing Body Mass Index: A Cross-Sectional Study

Glycosylated hemoglobin A1C (HbA1C) represented the percentage of hemoglobin that succumbed to non-enzymatic glycosylation of proteins, and was determined by chromatographic separation, photometric measurements at 415 nm (endpoint method).

Correlation between metabolic controls and changes in retina in patients having diabetes/Povezanost metabolicke regulacije sa promenama na ocnom dnu kod obolelih od secerne bolesti

Two prospective cohort studies evaluated the effect on glycemic control of a single glucocorticoid injection into the knee of patients with controlled type 2 diabetes (glycosylated hemoglobin A1c <7.0%).

Q/Do intra-articular steroid injections affect glycemic control in patients with diabetes?

The American Diabetes Association (ADA) recommends the following goals: glycosylated hemoglobin A1C (A1C) <7.0%; fasting plasma glucose (FPG) between 90 and 130 mg/dL; and peak postprandial glucose (PPG) <180 mg/dL.

Appropriate use of insulin analogs in an increasingly complex type 2 diabetes mellitus (T2DM) therapeutic landscape